The Next 2 Obesity Drug Stocks? Plus, Bitcoin’s Bounce
Barron's Streetwise
Barron's
4.7 • 1.6K Ratings
🗓️ 8 December 2023
⏱️ 31 minutes
🧾️ Download transcript
Summary
Transcript
Click on a timestamp to play from that location
| 0:00.0 | This episode is brought to you by Kraken. |
| 0:03.0 | Krypto is like the financial system, but different. |
| 0:06.0 | He doesn't care where you come from, |
| 0:08.0 | what you look like, your credit score, |
| 0:10.0 | or your outrageous food delivery habits. |
| 0:13.0 | crypto is financed for everyone, everywhere, all the time. |
| 0:17.0 | Visit Krakon.com slash see what crypto can be. |
| 0:21.0 | To learn more, Don't invest in |
| 0:23.5 | unless you're prepared to lose all the money you invest. |
| 0:25.7 | This is a high-risk investment and you should not expect to be |
| 0:28.0 | protected if something goes wrong. |
| 0:31.3 | This is probably one of the greatest opportunities in the history of drug development. |
| 0:37.0 | And that's why Lily and Nova are trading so well, and they're both up, I don't know how much, |
| 0:42.0 | over 300% both of them in the last five years or so |
| 0:45.5 | Investors look at that and they say how can I participate it did I already miss it |
| 0:52.4 | Hello and the |
| 0:53.3 | welcome to the Barron Streetwise podcast I'm Jack Howe and the voice you just |
| 0:57.2 | heard is Jay Olson he's a biotech analyst at Oppenheimer and in a moment he'll talk about investing in the |
| 1:05.0 | obesity drug revolution without just jumping into shares of Eli Lilly and |
| 1:10.8 | Novo Nordisk both of which are already up a lot. |
| 1:14.7 | Jay has two different ideas. |
| 1:17.0 | One is big and cheap, and the other is comparatively tiny. Speaking of which, listening in is our audio producer Jackson Cantrell. Hi Jackson. |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from Barron's, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Barron's and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.

